Literature DB >> 350728

Immunohistochemical localisation of urogastrone to human duodenal and submandibular glands.

P U Heitz, M Kasper, S van Noorden, J M Polak, H Gregory, A G Pearse.   

Abstract

Urogastrone has been localised by immunostaining to granules of the cells of human duodenal (Brunner's) glands and their ducts and of acinar cells in the human submandibular gland. The immunoreactive peptide is present in large quantities in duodenal glands and their secretory ducts. Urogastrone or human epidermal growth factor promotes cellular proliferation in vivo as well as in vitro and inhibits gastric acid secretion and may, therefore, be one of the duodenal factors inhibiting gastric activity. Thus it may have an important regulatory and protective function for the intestinal mucosa and may possibly become a useful therapeutic agent.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 350728      PMCID: PMC1412104          DOI: 10.1136/gut.19.5.408

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Effect of urogastrone on gastric secretion and plasma gastrin levels in normal subjects.

Authors:  J B Elder; P C Ganguli; I E Gillespie; E L Gerring; H Gregory
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

2.  Bifunctional reagents as vapour- and liquid-phase fixatives for immunohistochemistry.

Authors:  A G Pearse; J M Polak
Journal:  Histochem J       Date:  1975-03

3.  INHIBITION OF GASTRIC SECRETION BY EXTRACTS OF NORMAL MALE URINE.

Authors:  J S Gray; E Wieczorowski; A C Ivy
Journal:  Science       Date:  1939-05-26       Impact factor: 47.728

4.  Human epidermal growth factor and the proliferation of human fibroblasts.

Authors:  G Carpenter; S Cohen
Journal:  J Cell Physiol       Date:  1976-06       Impact factor: 6.384

5.  The primary structure of human urogastrone.

Authors:  H Gregory; B M Preston
Journal:  Int J Pept Protein Res       Date:  1977

6.  Urogastrone levels in the urine of normal adult humans.

Authors:  H Gregory; J E Holmes; I R Willshire
Journal:  J Clin Endocrinol Metab       Date:  1977-10       Impact factor: 5.958

7.  Proceedings: Cellular localization urogastrone by an immunofluorescent technique.

Authors:  J B Elder; G Williams; H Gregory
Journal:  Br J Surg       Date:  1976-08       Impact factor: 6.939

8.  Effect of urogastrone in the Zollinger-Ellison syndrome.

Authors:  J B Elder; I E Gillespie; P C Ganguli; W I Delamore; H Gregory
Journal:  Lancet       Date:  1975-09-06       Impact factor: 79.321

9.  Human urogastrone and mouse epidermal growth factor share a common receptor site in cultured human fibroblasts.

Authors:  M D Hollenberg; H Gregory
Journal:  Life Sci       Date:  1977-01-15       Impact factor: 5.037

10.  Mouse epidermal growth factor: light and electron microscopical localisation by immunocytochemical staining.

Authors:  S Van Noorden; P Heitz; M Kasper; A G Pearse
Journal:  Histochemistry       Date:  1977-06-24
View more
  45 in total

1.  Epidermal growth factor receptor inhibits colitis-associated cancer in mice.

Authors:  Philip E Dubé; Fang Yan; Shivesh Punit; Nandini Girish; Steven J McElroy; M Kay Washington; D Brent Polk
Journal:  J Clin Invest       Date:  2012-07-09       Impact factor: 14.808

2.  Immunohistochemical distribution of human epidermal growth factor in salivary gland tumours.

Authors:  M Mori; R Naito; K Tsukitani; Y Okada; T Hayashi; K Kato
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

3.  Why is epidermal growth factor present in the gut lumen?

Authors:  R J Playford; N A Wright
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

4.  Ménétrier's disease. A trivalent gastropathy.

Authors:  T M Sundt; C C Compton; R A Malt
Journal:  Ann Surg       Date:  1988-12       Impact factor: 12.969

5.  Immunohistochemical localization of epidermal growth factor in rat and man.

Authors:  S S Poulsen; E Nexø; P S Olsen; J Hess; P Kirkegaard
Journal:  Histochemistry       Date:  1986

6.  Sieving characteristics of cytokine- and peroxide-induced epithelial barrier leak: Inhibition by berberine.

Authors:  Katherine M DiGuilio; Christina M Mercogliano; Jillian Born; Brendan Ferraro; Julie To; Brittany Mixson; Allison Smith; Mary Carmen Valenzano; James M Mullin
Journal:  World J Gastrointest Pathophysiol       Date:  2016-05-15

Review 7.  The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.

Authors:  Kathryn J Rowland; Pamela M Choi; Brad W Warner
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

8.  Secretion of protein and epidermal growth factor (EGF) by transplanted human pancreas.

Authors:  J W Konturek; M Buesing; U T Hopt; J Stachura; H D Becker; S J Konturek
Journal:  Int J Pancreatol       Date:  1992-08

9.  Correlation between epidermal growth factor receptor concentration and the growth of human gastric cancer xenografts in nude mice.

Authors:  T Kiyama; M Onda; A Tokunaga; I Fujita; T Okuda; T Mizutani; T Yoshiyuki; Y Shimizu; K Nishi; N Matsukura
Journal:  Gastroenterol Jpn       Date:  1992-08

10.  Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies.

Authors:  J P Hong; S-W Lee; S Y Song; S D Ahn; S S Shin; E K Choi; J H Kim
Journal:  Eur J Cancer Care (Engl)       Date:  2009-04-23       Impact factor: 2.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.